Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage | MicrobiomeTrials← Back to trialsNCT05617833
Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2024-04-30Est. Completion: 2027-09
Enrollment target: 60 participants Locations- Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Lower Urinary Tract Obstruction, Congenital
The purpose of this research is to determine the feasibility and safety of performing fetal operative cystoscopy for the…
Rochester, United StatesCompleted Mar 23, 2056
Bronchopulmonary Dysplasia
It is intended to examine the short-term and long-term efficacy and safety of intravenous immunoglobulin(IVIG) for the b…
Shanghai, ChinaEst. completion Sep 2027
PediatricsNeurological AbnormalityNeurodevelopment Outcome
The American Academy of Pediatrics defines infants at risk as those with preterm birth, special health care needs, famil…
Kahramanmaraş, Turkey (Türkiye)Est. completion Sep 15, 2026